NDC 47426-302-06 - ZYNRELEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47426-302
- Requested NDC
- 47426-302-06
- Package NDCs from labels
- 47426-302-06, 47426-302-04, 47426-302-02
- Manufacturer
- Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZYNRELEF | Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47426-302-02 | ZYNRELEF | 1 in 1 KIT | SOLUTION | 1 | 16 | |
| 47426-302-04 | ZYNRELEF | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 47426-302-06 | ZYNRELEF | 10.5 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 10.5 | 16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MELOXICAM | MELOXICAM | Redpharm Drug | 5407aded-9f84-72ce-e063-6394a90ae672 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | St. Mary's Medical Park Pharmacy | fbe71312-0f9d-47c1-e053-6394a90a63a1 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | St. Mary's Medical Park Pharmacy | 60c954d5-bd5a-33f9-e053-2a91aa0ab597 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Emerald Therapeutics, LLC | 55af77dd-2abc-49a6-990c-399d5a5e7a91 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | St. Mary's Medical Park Pharmacy | 60c9ab35-4b6e-383d-e053-2a91aa0a26ad | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Coupler LLC | 52bd9bcd-4902-f9dd-e063-6294a90a604e | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | REMEDYREPACK INC. | fabd063a-d3a5-44a3-90a2-e33d721b7a95 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Proficient Rx LP | 459bd9c0-1102-46d3-8020-5fec80d1ec36 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 1ab45be4-b2b9-4374-95ab-620e0f90fb70 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | eae60d2c-411c-460a-b673-05b5784ed943 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Coupler LLC | 5071e1fd-5321-42cf-e063-6294a90a0ef6 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| ZYNRELEF | BUPIVACAINE AND MELOXICAM | Heron Therapeutics, Inc. | dab484a7-9353-43ba-9e74-7fab910c712b | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | NDA211988 47426-304-03 47426-501-04 47426-303-05 47426-302-06 47426-504-01 47426-304-01 47426-503-03 47426-304-05 47426-504-03 47426-502-02 47426-303-03 47426-301-04 47426-303-01 47426-302-04 47426-301-02 47426-301-06 47426-503-01 47426-502-04 47426-302-02 47426-501-02 47426-503 47426-301 47426-504 47426-303 47426-304 47426-502 47426-501 47426-302 47426030206 2560311 2560306 2560315 2560308 2560321 2560309 2560319 2560312 ab2a0921-41d7-4b3b-ace9-6adccb12c5e9 dab484a7-9353-43ba-9e74-7fab910c712b VG2QF83CGL Y8335394RO |
| MELOXICAM | MELOXICAM | Medcore LLC | 1160b6a8-d507-40b6-925b-25bf186daa30 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 1d8b617a-b9b3-473c-be9b-f34a585a1b3b | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Direct Rx | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9ce58c-3cd7-769f-e053-2a95a90a5385 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Golden State Medical Supply, Inc. | d27feaf7-731e-1a8f-e053-2a95a90afa71 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | fe41eca5-33f1-4ded-a177-d8f927f3f261 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | 2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | 7a4212a8-7761-4a77-aa18-ecf1f1244df2 | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.